CBLIF

gene
On this page

Also known as TCN3IFIFMHINF

Summary

CBLIF (cobalamin binding intrinsic factor, HGNC:4268) is a protein-coding gene on chromosome 11q12.1, encoding Cobalamin binding intrinsic factor (P27352). Promotes absorption of the essential vitamin cobalamin (Cbl) in the ileum.

This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia.

Source: NCBI Gene 2694 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): hereditary intrinsic factor deficiency (Strong, GenCC)
  • Clinical variants (ClinVar): 176 total — 9 pathogenic, 7 likely-pathogenic
  • Phenotypes (HPO): 26
  • MANE Select transcript: NM_005142

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4268
Approved symbolCBLIF
Namecobalamin binding intrinsic factor
Location11q12.1
Locus typegene with protein product
StatusApproved
AliasesTCN3, IF, IFMH, INF
Ensembl geneENSG00000134812
Ensembl biotypeprotein_coding
OMIM609342
Entrez2694

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 3 retained_intron, 1 protein_coding, 1 nonsense_mediated_decay

ENST00000257248, ENST00000525058, ENST00000532070, ENST00000533067, ENST00000533847

RefSeq mRNA: 1 — MANE Select: NM_005142 NM_005142

CCDS: CCDS7977

Canonical transcript exons

ENST00000257248 — 9 exons

ExonStartEnd
ENSE000011700035984537559845499
ENSE000021641055982927359829545
ENSE000035116705983717459837351
ENSE000035342245983167859831796
ENSE000035414135984387959844055
ENSE000035667755984302859843141
ENSE000036140415983580859836009
ENSE000036710745984244359842583
ENSE000036780285984114359841324

Expression profiles

Bgee: expression breadth ubiquitous, 141 present calls, max score 99.65.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6098 / max 1088.2645, expressed in 7 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1198830.60987

Top tissues by expression

281 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cardia of stomachUBERON:000116299.65gold quality
pylorusUBERON:000116698.03gold quality
body of stomachUBERON:000116190.18gold quality
stomachUBERON:000094589.77gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.54gold quality
fundus of stomachUBERON:000116087.26gold quality
buccal mucosa cellCL:000233672.78silver quality
diaphragmUBERON:000110367.09gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099166.35gold quality
pancreatic ductal cellCL:000207964.70silver quality
cervix squamous epitheliumUBERON:000692263.21gold quality
olfactory bulbUBERON:000226460.49gold quality
type B pancreatic cellCL:000016960.27gold quality
heart right ventricleUBERON:000208059.63gold quality
cardiac muscle of right atriumUBERON:000337959.58gold quality
left ventricle myocardiumUBERON:000656658.71gold quality
right lungUBERON:000216758.18gold quality
hair follicleUBERON:000207357.19gold quality
deciduaUBERON:000245056.92gold quality
ileal mucosaUBERON:000033156.30silver quality
myocardiumUBERON:000234955.22gold quality
thymusUBERON:000237054.16gold quality
nasal cavity epitheliumUBERON:000538453.64gold quality
endocervixUBERON:000045853.49gold quality
rectumUBERON:000105253.17gold quality
bloodUBERON:000017852.68gold quality
cranial nerve IIUBERON:000094152.59silver quality
cervix epitheliumUBERON:000480152.57gold quality
quadriceps femorisUBERON:000137752.17gold quality
uterine cervixUBERON:000000251.83gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.91

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CREB1, KLF10, NEUROG1, USF1, USF2

miRNA regulators (miRDB)

28 targeting CBLIF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-366299.9973.825684
HSA-MIR-314899.9775.066478
HSA-MIR-50799.9770.111915
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-129-5P99.8870.263273
HSA-MIR-44899.7972.372103
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-2681-5P99.7567.641655
HSA-MIR-3616-5P99.5567.02989
HSA-MIR-57399.5567.44955
HSA-MIR-1213199.4868.721673
HSA-MIR-1911-3P99.1566.17528
HSA-MIR-125399.1267.081688
HSA-MIR-4795-5P99.1166.90876
HSA-MIR-153-3P98.9672.511644
HSA-MIR-4716-5P98.8268.571168
HSA-MIR-937-5P97.4368.39667
HSA-MIR-3121-5P97.3066.621146
HSA-MIR-62096.9466.79888
HSA-MIR-127096.9466.65931
HSA-MIR-570296.6868.21958
HSA-MIR-4790-5P96.6767.45167
HSA-MIR-597-3P96.4668.031035
HSA-MIR-6753-5P94.7064.08470
HSA-MIR-367294.4665.67646
HSA-MIR-6864-3P94.4665.97625

Literature-anchored findings (GeneRIF, showing 12)

  • A polymorphism in the gastric intrinsic factor gene is associated with congenital intrinsic factor deficiency. (PMID:14695536)
  • The parameters obtained for ligand and receptor binding in this study indicate that both full-length 50-kDA intrinsic factor and its 30-kDa and 20-kDa fragments may be involved in assimilation of cobalamin. (PMID:15736970)
  • possible basis for the lack of interchangeability of human and rat IF receptors is presented (PMID:17954916)
  • The Q5R mutation of the intrinsic factor gene predisposes to adult-onset pernicious anemia & other causes of low vitamin B12. In this mutation, intrinsic factor secretion is preserved but B12 absorption may be impaired. (PMID:18338170)
  • a specific GIF mutation to be responsible for all Juvenile cobalamin deficiency cases of West-African origin so far was identified (PMID:19036097)
  • crystal structure of the complex between IF-Cbl and the cubilin IF-Cbl-binding-region (CUB(5-8)) determined at 3.3 A resolution (PMID:20237569)
  • Acute lymphoblastic leukemia and vitamin B12 deficiency secondary to a gastric intrinsic factor gene mutation (PMID:22556038)
  • Our genetic screening of 154 families of patients with inherited cobalamin malabsorption revealed population-specific mutations, mutational hotspots, and functionally distinct regions in the three causal genes: CUBN, AMN, and GIF. (PMID:22929189)
  • study reports that FUT2 secretor variant influences GIF secretion in B12 deficient cases bearing GIF heterozygous mutations, in absence of H. pylori related gastritis (PMID:23402911)
  • the present findings reveal that High-altitude polycythemia -induced gastric mucosal lesion inspires the protection responses by up-regulating APOA4 and APOC3, and down-regulating GIF. (PMID:26485402)
  • The gastric intrinsic factor (GIF) 290C heterozygous/fucosyltransferase 2 (secretor status included) protein (FUT2) rs601338 secretor variant combined genotype was indicated in 6 of the 37 neural tube defects (NTDs) fetuses. (PMID:28742214)
  • Pancytopenia and megaloblastic erythropoiesis reveal a novel GIF mutation. (PMID:29368379)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusCblifENSMUSG00000024682
rattus_norvegicusCblifENSRNOG00000021001
drosophila_melanogasterCG3556FBGN0029708

Paralogs (2): TCN1 (ENSG00000134827), TCN2 (ENSG00000185339)

Protein

Protein identifiers

Cobalamin binding intrinsic factorP27352 (reviewed: P27352)

Alternative names: Gastric intrinsic factor, Intrinsic factor

All UniProt accessions (2): P27352, E9PM21

UniProt curated annotations — full annotation on UniProt →

Function. Promotes absorption of the essential vitamin cobalamin (Cbl) in the ileum. After interaction with CUBN, the CBLIF-cobalamin complex is internalized via receptor-mediated endocytosis.

Subunit / interactions. Interacts with CUBN (via CUB domains).

Subcellular location. Secreted.

Tissue specificity. Gastric mucosa.

Disease relevance. Hereditary intrinsic factor deficiency (IFD) [MIM:261000] Autosomal recessive disorder characterized by megaloblastic anemia. The disease is caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the eukaryotic cobalamin transport proteins family.

Isoforms (2)

UniProt IDNamesCanonical?
P27352-11yes
P27352-22

RefSeq proteins (1): NP_005133* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002157Cbl-bd_protFamily
IPR051588Cobalamin_TransportFamily

Pfam: PF01122

UniProt features (53 total): helix 18, strand 8, binding site 5, glycosylation site 4, sequence variant 4, sequence conflict 4, disulfide bond 3, turn 3, signal peptide 1, chain 1, splice variant 1, modified residue 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
2PMVX-RAY DIFFRACTION2.6
3KQ4X-RAY DIFFRACTION3.3

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P27352-F190.690.83

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (5): 171; 222; 270; 365–370; 386–395

Post-translational modifications (1): 191

Disulfide bonds (3): 26–246, 103–288, 143–182

Glycosylation sites (4): 334, 413, 311, 330

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-3359457Defective CBLIF causes IFD
R-HSA-3359462Defective AMN causes MGA1
R-HSA-3359463Defective CUBN causes MGA1
R-HSA-9758881Uptake of dietary cobalamins into enterocytes

MSigDB gene sets: 155 (showing top): GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_VITAMIN_TRANSPORT, MORF_EPHA7, MORF_RAB3A, GOCC_APICAL_PLASMA_MEMBRANE, LEE_CALORIE_RESTRICTION_NEOCORTEX_UP, MORF_WNT1, VECCHI_GASTRIC_CANCER_EARLY_DN, MCCLUNG_COCAIN_REWARD_4WK, MORF_IL9, GOBP_TRANSMEMBRANE_TRANSPORT, MORF_DCC, AP1FJ_Q2, GOCC_LYSOSOMAL_LUMEN

GO Biological Process (3): cobalt ion transport (GO:0006824), cobalamin transport (GO:0015889), monoatomic ion transport (GO:0006811)

GO Molecular Function (4): cobalamin binding (GO:0031419), molecular carrier activity (GO:0140104), cargo receptor ligand activity (GO:0140355), protein binding (GO:0005515)

GO Cellular Component (6): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), endosome (GO:0005768), microvillus (GO:0005902), apical plasma membrane (GO:0016324), lysosomal lumen (GO:0043202)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Defects in cobalamin (B12) metabolism3
Cobalamin (Cbl, vitamin B12) transport and metabolism1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding2
transition metal ion transport1
monoatomic cation transmembrane transport1
vitamin transport1
nitrogen compound transport1
transport1
vitamin binding1
tetrapyrrole binding1
heterocyclic compound binding1
molecular_function1
protein binding1
cellular anatomical structure1
endomembrane system1
cytoplasmic vesicle1
actin filament bundle1
actin-based cell projection1
apical part of cell1
plasma membrane region1
lysosome1
vacuolar lumen1

Protein interactions and networks

STRING

448 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CBLIFCUBNO60494984
CBLIFAMNQ9BXJ7899
CBLIFCBLP22681815
CBLIFLRP2P98164793
CBLIFC1RP00736711
CBLIFC1SP09871694
CBLIFATP4BP51164676
CBLIFLDLRAP1Q5SW96639
CBLIFTFF2Q03403633
CBLIFBMP1P13497592
CBLIFGASTP01350567
CBLIFCD320Q9NPF0560
CBLIFMUC6Q6W4X9531
CBLIFLTFP02788524
CBLIFGCP02774515

IntAct

29 interactions, top by confidence:

ABTypeScore
CBLIFSLC7A14psi-mi:“MI:0915”(physical association)0.560
CBLIFFFAR2psi-mi:“MI:0915”(physical association)0.560
CBLIFSLC13A4psi-mi:“MI:0915”(physical association)0.560
CBLIFTMEM237psi-mi:“MI:0915”(physical association)0.560
SLC22A23CBLIFpsi-mi:“MI:0915”(physical association)0.560
CBLIFSLC7A1psi-mi:“MI:0915”(physical association)0.560
FFAR2CBLIFpsi-mi:“MI:0915”(physical association)0.560
CBLIFCUBNpsi-mi:“MI:0407”(direct interaction)0.560
ZNF354CLRP4psi-mi:“MI:0914”(association)0.530
SLC5A9CD63psi-mi:“MI:0914”(association)0.530
CBLIFCBLIFpsi-mi:“MI:0407”(direct interaction)0.440
CBLIFHSPA8psi-mi:“MI:0915”(physical association)0.400
GALNT5CBLIFpsi-mi:“MI:0915”(physical association)0.400
CBLIFFBXO2psi-mi:“MI:0915”(physical association)0.400
EBNA1IGF2BP3psi-mi:“MI:0914”(association)0.350
SPASTCBLIFpsi-mi:“MI:0914”(association)0.350
CBLIFSLC13A4psi-mi:“MI:0915”(physical association)0.000
CBLIFTMEM237psi-mi:“MI:0915”(physical association)0.000
CBLIFSLC7A1psi-mi:“MI:0915”(physical association)0.000
CBLIFSLC22A23psi-mi:“MI:0915”(physical association)0.000

BioGRID (18): FBXO2 (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Two-hybrid), GIF (Two-hybrid), SLC22A23 (Two-hybrid), SLC7A1 (Two-hybrid), TMEM237 (Two-hybrid), SLC13A4 (Two-hybrid), GIF (Proximity Label-MS), GIF (Reconstituted Complex), FBXO2 (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS)

ESM2 similar proteins: A2RT67, A4D0V7, A4FV27, A6NFY4, D2XPP7, D3Z2R5, O18638, O70367, O75129, O75829, O77770, P0CG01, P17267, P17404, P20362, P24405, P27352, P40682, P45641, P52787, P54863, P79894, Q2MV58, Q3U128, Q52LC2, Q5PPI4, Q5R2I8, Q5R2J4, Q5RBY5, Q62522, Q66KI8, Q6DF34, Q6E211, Q6PGD0, Q6Q2W4, Q6UW56, Q7Z7H3, Q8CB65, Q8J025, Q95LL7

Diamond homologs: P17267, P20061, P27352, P52787, Q5XWD5, P17630, P20062, Q5REL7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

176 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic9
Likely pathogenic7
Uncertain significance77
Likely benign52
Benign15

Top pathogenic / likely-pathogenic (16)

Variant IDHGVSClassification
1745NM_005142.3(CBLIF):c.80-1G>APathogenic
1747NM_005142.3(CBLIF):c.161del (p.Asn54fs)Pathogenic
1748NM_005142.3(CBLIF):c.1175dup (p.Thr393fs)Pathogenic
208191NM_005142.3(CBLIF):c.346C>T (p.Gln116Ter)Pathogenic
2903417NM_005142.3(CBLIF):c.310C>T (p.Arg104Ter)Pathogenic
3721037NM_005142.3(CBLIF):c.659T>C (p.Ile220Thr)Pathogenic
439755NM_005142.3(CBLIF):c.79+1G>APathogenic
4749260NM_005142.3(CBLIF):c.52_56del (p.Thr18fs)Pathogenic
566919NM_005142.3(CBLIF):c.183_186del (p.Met61fs)Pathogenic
1746NM_005142.3(CBLIF):c.137C>T (p.Ser46Leu)Likely pathogenic
1969715NM_005142.3(CBLIF):c.370+83_426delLikely pathogenic
2425302NC_000011.9:g.(?59603261)(59604844_?)dupLikely pathogenic
2431712NM_005142.3(CBLIF):c.370+1G>CLikely pathogenic
3362465NM_005142.3(CBLIF):c.395_396delinsAA (p.Phe132Ter)Likely pathogenic
3766532NM_005142.3(CBLIF):c.67_68del (p.Gln23fs)Likely pathogenic
830018NM_005142.3(CBLIF):c.661G>A (p.Gly221Arg)Likely pathogenic

SpliceAI

1202 predictions. Top by Δscore:

VariantEffectΔscore
11:59837348:GAGC:Gacceptor_gain1.0000
11:59837349:AGCC:Aacceptor_loss1.0000
11:59837350:GC:Gacceptor_gain1.0000
11:59837351:CC:Cacceptor_gain1.0000
11:59837352:CTGGG:Cacceptor_loss1.0000
11:59837353:T:Aacceptor_loss1.0000
11:59841325:C:CCacceptor_gain1.0000
11:59842587:C:CTacceptor_gain1.0000
11:59842588:G:Tacceptor_gain1.0000
11:59843008:C:CAdonor_gain1.0000
11:59843026:A:ACdonor_gain1.0000
11:59843027:C:CCdonor_gain1.0000
11:59843873:TCTCA:Tdonor_loss1.0000
11:59843874:CTCA:Cdonor_loss1.0000
11:59843875:TCACC:Tdonor_loss1.0000
11:59843876:CACC:Cdonor_loss1.0000
11:59843877:A:ACdonor_gain1.0000
11:59843877:A:Cdonor_loss1.0000
11:59843878:C:CCdonor_gain1.0000
11:59844053:CGG:Cacceptor_gain1.0000
11:59845374:CAG:Cdonor_gain1.0000
11:59829543:CCC:Cacceptor_gain0.9900
11:59829543:CCCCT:Cacceptor_loss0.9900
11:59829544:CCC:Cacceptor_gain0.9900
11:59829545:CCTG:Cacceptor_loss0.9900
11:59829546:CT:Cacceptor_loss0.9900
11:59829547:T:Aacceptor_loss0.9900
11:59831797:C:CCacceptor_gain0.9900
11:59835806:A:ACdonor_gain0.9900
11:59835807:C:CCdonor_gain0.9900

AlphaMissense

2744 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:59831712:C:AW386C0.991
11:59831712:C:GW386C0.991
11:59831714:A:GW386R0.990
11:59831714:A:TW386R0.990
11:59829504:C:GA412P0.986
11:59829503:G:TA412D0.982
11:59835833:C:GA350P0.978
11:59841297:A:GL180P0.978
11:59842546:A:CS136R0.978
11:59842546:A:TS136R0.978
11:59842548:T:GS136R0.978
11:59843106:C:GA98P0.976
11:59837313:C:AW244C0.974
11:59837313:C:GW244C0.974
11:59831713:C:GW386S0.972
11:59841292:A:GC182R0.971
11:59837230:A:GL272P0.969
11:59843947:A:GL63P0.969
11:59841290:A:CC182W0.968
11:59831793:A:CF359L0.967
11:59831793:A:TF359L0.967
11:59831795:A:GF359L0.967
11:59842525:G:CC143W0.967
11:59835810:G:CF357L0.966
11:59835810:G:TF357L0.966
11:59835812:A:GF357L0.966
11:59835935:A:CY316D0.966
11:59842527:A:GC143R0.966
11:59831761:A:TV370D0.965
11:59837239:G:TA269D0.965

dbSNP variants (sampled 300 via entrez): RS1000067116 (11:59831417 T>C), RS1000553130 (11:59834539 C>T), RS1000716897 (11:59828830 T>C), RS1000966650 (11:59847443 A>T), RS1000985388 (11:59840989 A>C,G), RS1001016630 (11:59840536 A>C), RS1001310716 (11:59847077 A>G), RS1001333685 (11:59837700 T>C), RS1001338574 (11:59831146 T>C), RS1001461489 (11:59844800 T>C), RS1001489258 (11:59834249 T>A,C), RS1001720440 (11:59835452 A>G), RS1001842727 (11:59830706 T>C), RS1001924823 (11:59833933 A>G), RS1001968500 (11:59841950 C>G,T)

Disease associations

OMIM: gene MIM:609342 | disease phenotypes: MIM:261000

GenCC curated gene-disease

DiseaseClassificationInheritance
hereditary intrinsic factor deficiencyStrongAutosomal recessive

Mondo (1): hereditary intrinsic factor deficiency (MONDO:0009852)

Orphanet (1): Congenital intrinsic factor deficiency (Orphanet:332)

HPO phenotypes

26 total (26 of 26 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000726Dementia
HP:0001328Specific learning disability
HP:0001510Growth delay
HP:0001889Megaloblastic anemia
HP:0002160Hyperhomocystinemia
HP:0002315Headache
HP:0002719Recurrent infections
HP:0002912Methylmalonic acidemia
HP:0003401Paresthesia
HP:0003474Somatic sensory dysfunction
HP:0003621Juvenile onset
HP:0005219Absence of intrinsic factor
HP:0005518Increased mean corpuscular volume
HP:0006827Atrophy of the spinal cord
HP:0009830Peripheral neuropathy
HP:0011463Childhood onset
HP:0012120Methylmalonic aciduria
HP:0020181Reduced haptoglobin level
HP:0025406Asthenia
HP:0025435Increased circulating lactate dehydrogenase concentration
HP:0031965Increased RBC distribution width
HP:0100502Decreased circulating vitamin B12 concentration
HP:0200118Malabsorption of Vitamin B12
HP:0200143Megaloblastic erythroid hyperplasia
HP:6000344Anti-intrinsic factor antibody positivity

GWAS associations

0 associations (top):

MeSH disease descriptors (1)

DescriptorNameTree numbers
C563242Intrinsic Factor Deficiency (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608affects binding, increases reaction1
Benzo(a)pyreneaffects methylation1
Cadmiumdecreases expression1
Free Radicalsaffects metabolic processing1
Tetradecanoylphorbol Acetateaffects cotreatment, affects expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoinaffects expression1
Zincaffects cotreatment, affects expression1
Hydroxyl Radicalaffects metabolic processing1

Cellosaurus cell lines

1 cell lines: 1 finite cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B3YSWG2436Finite cell lineFemale

Clinical trials (associated diseases)

1 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT03655223Not specifiedENROLLING_BY_INVITATIONEarly Check: Expanded Screening in Newborns